Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LCK | P06239 | 1/20 | 0.41 |
| ▸ | FYN | P06241 | 1/20 | 0.41 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.37 |
| ▸ | AKR1C2 | P52895 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | GFER | P55789 | 1/20 | 0.35 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.35 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.34 |
| ▸ | GCK | P35557 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22926107 | 1.00 | LCK (0.41) | LCKFYNMRGPRX4LMNAAKR1C3 | |
| SCHEMBL29903378 | 0.86 | VNN1 (0.36) | LMNAAKR1C3AKR1C2ALDH1A1MAPT | |
| SCHEMBL29283330 | 0.85 | LCK (0.37) | LCKFYNLMNAAKR1C3AKR1C2 | |
| SCHEMBL31401419 | 0.84 | LCK (0.41) | LCKFYNMRGPRX4LMNAALDH1A1 | |
| SCHEMBL27893362 | 0.81 | MRGPRX4 (0.47) | LCKFYNMRGPRX4LMNAAKR1C3 | |
| SCHEMBL4235825 | 0.81 | MRGPRX4 (0.47) | MRGPRX4LMNAAKR1C3ALDH1A1MAPT | |
| SCHEMBL30263022 | 0.81 | TSHR (0.42) | LCKFYNAKR1C3ALDH1A1MAPT | |
| SCHEMBL29283331 | 0.81 | TSHR (0.42) | LCKFYNAKR1C3ALDH1A1MAPT | |
| SCHEMBL5620234 | 0.80 | RXRA (0.46) | LCKFYNAKR1C3ALDH1A1GAA | |
| SCHEMBL23464784 | 0.80 | AKR1C3 (0.39) | LCKFYNMRGPRX4LMNAAKR1C3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114761402-A | Novel heteroaryl-triazole compounds as pesticides | 拜耳公司 | 2022-07-15 | — | — | CN | claimed |
| EP-4739682-A1 | 1,6-NAPHTHRIDINE COMPOUNDS AS SMARCA2 INHIBITORS USEFUL FOR THE TREATMENT OF SMARCA4 DEFICIENT CANCERS | Janssen Pharmaceutica NV (BE) | 2026-05-13 | — | — | EP | disclosed |
| CN-115996639-B | Novel heteroaryl-triazole compounds as pesticides | 拜耳公司 | 2025-06-13 | — | — | CN | disclosed |
| WO-2025008058-A1 | 1,6-NAPHTHRIDINE COMPOUNDS AS SMARCA2 INHIBITORS USEFUL FOR THE TREATMENT OF SMARCA4 DEFICIENT CANCERS | JANSSEN PHARMACEUTICA NV (BE) | 2025-01-09 | — | — | WO | disclosed |
| CN-118561817-A | Novel heteroaryl-triazole compounds as pesticides | 拜耳公司 | 2024-08-30 | — | — | CN | disclosed |
| CN-118496198-A | Novel heteroaryl-triazole compounds as pesticides | 拜耳公司 | 2024-08-16 | — | — | CN | disclosed |
| CN-115996639-A | Novel heteroaryl-triazole compounds as pesticides | 拜耳公司 | 2023-04-21 | — | — | CN | disclosed |
| US-20230065953-A1 | NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2023-03-02 | — | — | US | disclosed |
| EP-4065577-A1 | NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES | Bayer Aktiengesellschaft (DE) | 2022-10-05 | — | — | EP | disclosed |
| CN-114761402-A | Novel heteroaryl-triazole compounds as pesticides | 拜耳公司 | 2022-07-15 | — | — | CN | disclosed |
| EP-4003974-A1 | NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES | Bayer Aktiengesellschaft (DE) | 2022-06-01 | — | — | EP | disclosed |
| CN-114502545-A | Novel heteroaryl-triazole compounds as pesticides | 拜耳公司 | 2022-05-13 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230065953-A1 | NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES | GLRX3, TARS2, CYP4F3 | LCK 4087/4885FYN 3111/4885MRGPRX4 633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.